A Meta-analysis Comparing Toothbrushes on Plaque Removal and Gingival Health
Launched by PROCTER AND GAMBLE · Oct 21, 2022
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Subjects were excluded from this study for the following reasons;
- • pregnancy,
- • rampant caries,
- • severe periodontitis,
- • at discretionary of the Principal Investigator.
About Procter And Gamble
Procter & Gamble (P&G) is a leading global consumer goods company with a strong commitment to improving the lives of consumers through innovative products and scientific research. Established in 1837, P&G has a diverse portfolio that includes well-known brands in health, hygiene, and personal care. The company actively engages in clinical trials to ensure the safety and efficacy of its products, leveraging advanced research methodologies and ethical standards to contribute to advancements in consumer health and wellness. By prioritizing quality and consumer trust, P&G aims to deliver superior solutions that enhance everyday life for individuals and families around the world.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cincinnati, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials